GENFIT TOWARDS BETTER MEDICINE
LIVE

Serial Number

79443783

Owner

GENFIT

Attorney

Ronald M. Kachmarik

Filing Date

Jan 22, 2026

Add to watchlist:

No watchlists yet
View on USPTO

GENFIT TOWARDS BETTER MEDICINE Trademark

Serial Number: 79443783

GENFIT TOWARDS BETTER MEDICINE is a trademark filed by GENFIT on January 22, 2026. The trademark is classified under Class 1 (Chemicals). The application is currently pending registration.

Owner Contact Info

GENFIT (51 trademarks)

885 rue Eugene Avinee
Loos 59120 , FR

Entity Type: 03

Trademark Details

Filing Date

January 22, 2026

Registration Date

Not Registered

Published for Opposition

September 8, 2026

Goods & Services

Reagents for scientific use; reagents for medical research; diagnostic reagents for scientific use; reagents for medical research, namely, immunoserology and molecular diagnosis; chemical reagents for genetic research; reagents for scientific or medical research; in-vivo diagnostic reagents for scientific use; diagnostic reagents for scientific use or for research; diagnostic reagents for in-vitro use in biochemistry, molecular biology, clinical chemistry and microbiology research.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2026 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 12, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 27, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 27, 2026 TROA
REFUSAL PROCESSED BY IB
Jul 23, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 7, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jul 7, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 21, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 20, 2026 CNRT
ASSIGNED TO EXAMINER
May 19, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 15, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2026 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Feb 12, 2026 SDRC